GRGary W. Raff

Gary W. Raff

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gary W. Raff has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Microvascular preservation and cardiomyocyte hyperplasia underlie adaptive right ventricle development in congenital heart disease-pulmonary arterial hypertension

    by Michael A. Smith, Eleana S. Guardado, Jason Boehme, Sanjeev A. Datar, Emin Maltepe, Naveen Swami, Gary W. Raff, Aaron Bodansky, Prakash Chelladurai, Joseph Moreno, et al.

    In this study, we utilize an ovine model of congenital heart disease-associated pulmonary arterial hypertension (CHD-PAH) to unveil the structural and transcriptional changes that underlie the maintenance of an adaptively hypertrophied right ventricle (RV). In CHD-PAH, the RV hypertrophies while maintaining microvascular density and expanding its cardiomyocyte population, structural and cellular adaptations that are critical to supporting RV function. These findings provide novel insight into myocardial growth mechanisms that are triggered by congenital pressure overload.


  • Authors’ Reply: Pediatric Intranodal CT Lymphangiography with Water-Soluble Contrast Media

    by Zachary B. Jenner, Peter Li, Lisa Kang, Brian W. Goldner, Colin N. Brown, Gary W. Raff, John Kaufman

  • Delayed Diagnosis and Treatment of an Occult Hemothorax Following Complicated Central Line Insertion Leads to Cardiac Arrest

    by Gary Raff, Brian Goudy

    A 2-year-old girl with acute myelogenous leukemia and thrombocytopenia (platelet count 26,000 per microliter) with marked generalized petechiae and bruising was scheduled for implantation of a central venous catheter with a subcutaneous port. After reviewing the patient’s electronic health records but without seeing the patient, who was in another hospital, the anesthetist asked the surgeon to order a platelet transfusion to increase the child’s platelet count to above 50,000 per microliter. The patient was transported to the operating room while still receiving the platelet transfusion, so a follow-up platelet count had not yet been obtained.After induction of general anesthesia, the assistant surgeon tried 10 times to cannulate either subclavian vein without using ultrasound guidance. He finally succeeded in cannulating the left subclavian vein and, after fluoroscopically confirming that the tip of the catheter was in the lower half of the superior vena cava, he closed the wound. The patient was then awakened from general anesthesia and transferred to the post-anesthesia care unit. The surgeons had not noticed a moderate left-sided hemothorax on the post-procedure chest radiograph. This finding was reported by the on-duty radiologist but not conveyed to the surgeons. The anesthesiologist, who remained in the operating room, was called to see the patient who was pale, crying inconsolably, with fluctuating blood pressure. Realizing the seriousness of the child’s bleeding condition, he alerted the patient’s surgeons and the pediatric intensive care physician, but they were unable to arrive at the child’s bedside for 30 minutes and 45 minutes, respectively, so the anesthesiologist ordered blood for an urgent transfusion. Before the child could be transfused, she suddenly collapsed and developed cardiac arrest accompanied by pulseless electrical activity (PEA). A “code blue” was called and the child was successfully resuscitated after about 20 minutes, following insertion of a thoracostomy drainage (chest) tube.Unfortunately, the surgeon had damaged an intercostal artery when he inserted the chest tube emergently, which caused further bleeding and two additional episodes of PEA arrest. The patient required bedside thoracotomy and a prolonged pediatric intensive care unit (PICU) stay, during which she developed a subdural hematoma and ischemic encephalopathy.This case highlights a cascade of preventable iatrogenic events after a common procedure that is generally considered low-risk. The delay in diagnosis and subsequent treatment of a hemothorax resulted in a preventable and devastating series of events. Both errors in judgment and errors in technique occurred, and the attending surgeon was ultimately responsible for the outcome. One of the primary roles of the surgical team is to mitigate risk once the risks and benefits of the planned procedure have been assessed and the surgeon agrees to perform the procedure. For central line insertions, the risks include initial catheter malposition and bleeding. The proceduralist must also be on the lookout for injury to surrounding structures (such as arteries, other veins, nerves, thoracic duct, lung, trachea, etc.) and perforations of the vein being accessed or large central veins or heart. If the catheter is malpositioned, it can contribute to delayed complications such as erosion of the catheter through the vein wall or heart, vessel thrombosis, vessel stenosis, and infection (such as central line-associated blood stream infection [CLABSI] or endocarditis). Occlusion of the central line and embolization of thrombus or air from careless flushing of the catheter are also known risks, especially in children with congenital heart disease and complete mixing lesions.1,2In this case, the patient was thrombocytopenic with clinical evidence of coagulopathy. Appropriately, a platelet transfusion was ordered and was running while the patient was on the way to the operating room. A follow-up platelet count would have provided some assurance that the procedure could be performed safely, with a manageable risk of serious bleeding.The next issue the surgeon had to address was choosing a surgical approach that would be most appropriate for this patient. In patients at serious risk for bleeding after central line placement, peripheral cannulation is a reasonable alternative to subclavian vein cannulation. Indeed, Kanji et al. showed that in patients undergoing extracorporeal membrane oxygenation, peripheral cannulation was associated with a marked reduction in blood product utilization (i.e., packed red blood cells, platelets, fresh frozen plasma, and cryoprecipitate transfusions) as well as decreased incidence of bleeding from the cannulation site (18% vs 64%).3 Although the patient population in that study had a different indication for central venous access than the patient in the current case, one can reasonably infer that peripheral cannulation would also be safer in patients with similar preexisting coagulopathy (such as a thrombocytopenic patient with a hematologic malignancy). In patients such as the two-year-old in this case, the risk of bleeding into the pleural space must be minimized as such bleeding is difficult to detect until there is a hemodynamic embarrassment, compared with bleeding outside the pleural space, such as in a subcutaneous tunnel. A facial vein cutdown or external jugular vein cutdown would have been safer approaches in this case, as these procedures mitigate the risk of bleeding and pneumothorax compared with the typical subclavian vein or internal jugular vein approach.1 Implanting chemotherapy ports via the external jugular vein is a reliable and safe approach in patients requiring long-term chemotherapy.4 Furthermore, in a retrospective analysis of pediatric patients, Bawazier et al. showed that Hickman central venous catheters inserted via open cutdown of the external jugular...

  • Utility of Routine Head Ultrasounds in Infants on Extracorporeal Life Support: When is it Safe to Stop Scanning?

    by Christina M. Theodorou, Timothy M. Guenther, Kaitlyn L. Honeychurch, Laura Kenny, Stephanie N. Mateev, Gary W. Raff, Alana L. Beres

    Intracranial hemorrhage (ICH) can be a devastating complication of extracorporeal life support (ECLS); however, studies on the timing of ICH detection by head ultrasound (HUS) are from 2 decades ago, suggesting ICH is diagnosed by day 5 of ECLS. Given advancements in imaging and critical care, our aim was to evaluate if the timing of ICH diagnosis in infants on ECLS support has changed. Patients <6 months old undergoing ECLS 2011–2020 at a tertiary care children’s hospital were included. Primary outcome was timing of ICH diagnosis on HUS. Seventy-four infants underwent ECLS for cardiac (54%) or pulmonary (46%) indications. Venoarterial ECLS was most common (88%). Median ECLS duration was 6 days (range 1–26). Sixteen patients were diagnosed with ICH (21.6%), at a median of 2 days postcannulation (range 1–4). Nearly all were <4 weeks old at cannulation (93.8%). In conclusion, one-fifth of infants developed ICH diagnosed by HUS while on ECLS, all within the first 4 days of ECLS, consistent with previous literature. Despite advances in critical care and imaging technology, the temporality of ICH diagnosis in infants on ECLS is unchanged.

  • Pulse Oximetry in Children with Congenital Heart Disease: Effects of Cardiopulmonary Bypass and Cyanosis

    by Adalberto Torres, Kelly M. Skender, Julie D. Wohrley, Jean C. Aldag, Gary W. Raff, G. Kris Bysani, Dale M. Geiss

    The objective of this prospective, observational study with consecutive sampling was to assess the reliability, bias, and precision of Nellcor N-395 (N) and Masimo SET Radical (M) pulse oximeters in children with cyanotic congenital heart disease and children with congenital heart disease recovering from cardiopulmonary bypass-assisted surgery admitted to a cardiovascular operating suite and pediatric intensive care unit at a tertiary care community hospital. Forty-six children with congenital heart disease were studied in 1 of 2 groups: (1) those recovering from cardiopulmonary bypass with a serum lactic acid > 2 mmol/L, and (2) those with co-oximetry measured saturations (SaO 2) < 90% and no evidence of shock. Measurements of SaO 2 of whole blood were compared to simultaneous pulse oximetry saturations (SpO 2). Data were analyzed to detect significant differences in SpO 2 readout failures between oximeters and average SpO 2 - SaO 2 ± 1 SD for each oximeter. A total of 122 SaO 2 measurements were recorded; the median SaO 2 was 83% (57 - 100%). SpO 2 failures after cardiopulmonary bypass were 41% (25/61) for N versus 10% (6/61) for M ( P < .001). There was a significant difference in bias (ie, average SpO 2 - SaO 2) and precision (± 1 SD) between oximeters (N, 1.1 ± 3.3 vs M, -0.2 ± 4.1; P < .001) in the postcardiopulmonary bypass group but no significant difference in bias and precision between oximeters in the cyanotic congenital heart disease group (N, 2.9 ± 4.6 vs M, 2.8 ± 6.2; P = .848). The Nellcor N-395 pulse oximeter failed more often immediately after cardiopulmonary bypass than did the Masimo SET Radical pulse oximeter. SpO2 measured with both oximeters overestimated SaO2 in the presence of persistent hypoxemia.